Abstract
This case report describes successful treatment of autoimmune autonomic ganglionopathy (AAG) in a 74-year-old woman by total plasma exchanges (PLEX) and rituximab. Two series of PLEX temporarily, but dramatically improved orthostatic intolerance and hypotension and baroreflex function, in a manner inversely related to ganglionic neuronal nicotinic receptor antibody titer. After rituximab treatment, the antibody titer was decreased modestly but persistently, and the patient had symptomatic and clinical laboratory evidence of continued benefit for at least 10 months, supporting the autoimmune pathogenesis of AAG.
References
Goldstein DS, Holmes C, Dendi R, Li ST, Brentzel S, Vernino S (2002) Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin Auton Res 12:281–285
Schroeder C, Vernino S, Birkenfeld AL, Tank J, Heusser K, Lipp A, Benter T, Lindschau C, Kettritz R, Luft FC, Jordan J (2005) Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353:1585–1590
Stubgen JP (2008) B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders. J Neuroimmunol 204(1–2):1–12
Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA (2008) Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol 197:63–69
Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343:847–855
Acknowledgments
The authors acknowledge Dr. Kaho Wong, MD who administered rituximab to the patient. The authors thank clinical support personnel of the Clinical Neurocardiology Section, including Sandra Pechnik, RN, LaToya Sewell, CRNP, and Tereza Jenkins. The study was supported by the intramural research program of the NINDS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imrich, R., Vernino, S., Eldadah, B.A. et al. Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab. Clin Auton Res 19, 259–262 (2009). https://doi.org/10.1007/s10286-009-0012-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-009-0012-7